Navigation Links
InspireMD Reports Financial Results For Period Ended March 31, 2013
Date:5/8/2013

or the 1,114-patient trial, which will be conducted at 70 sites in the U.S. and Europe, will be Gregg Stone, MD, of the Cardiovascular Research Foundation in New York and Jose P.S. Henriques, MD, of the Academic Medical Center Amsterdam in The Netherlands.

Upcoming EventsInspireMD will host a symposium with key opinion leaders to review six month follow up data from the Company's multi-center MASTER trial of the MGuard Embolic Protection Stent.  The meeting will take place at the EuroPCR meeting in Paris, France on Thursday, May 23rd at 12:00pm Paris time. 

About Stenting and MGuard™ EPS™Standard stents were not engineered for heart attack patients. They were designed for treating stable angina patients whose occlusion is different from that of an occlusion in a heart attack patient.

In acute heart attack patients, the plaque or thrombus is unstable and often breaks up as the stent is implanted causing downstream blockages (some of which can be fatal) in a significant portion of heart attack patients.

The MGuard EPS is integrated with a precisely engineered micro net mesh that prevents the unstable arterial plaque and thrombus (clots) that caused the heart attack blockage from breaking off.

While offering superior performance relative to standard stents in STEMI patients with regard to ST segment resolution, the MGuard EPS requires no change in current physician practice - an important factor in promoting acceptance and general use in time-critical emergency settings.

About InspireMD, Inc.InspireMD is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard. InspireMD intends to pursue applications of this technology in coronary, carotid and peripheral artery procedures. InspireMD's common stock is quoted on the NYSE MKT under the ticker symbol NSPR.

MGuard EPS is CE Mark approved. It is not approved for sale in the
'/>"/>

SOURCE InspireMD, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. InspireMD Receives Approval From US Food and Drug Administration to Begin US Regulatory Trial
2. InspireMD Closes $25 Million Underwritten Public Offering
3. InspireMD Announces Pricing of Underwritten Public Offering of Common Stock and Listing on NYSE MKT
4. InspireMD Receives CE Mark Approval for Carotid Embolic Protection Stent
5. InspireMD Files Amended Registration Statement for Proposed Public Offering of Common Stock
6. InspireMD Reports Results for Period Ended Dec. 31, 2012
7. InspireMD to Discuss MGuard(TM) and the MASTER Randomized Trial Results at the ICI 2012 Meeting
8. Positive Results of InspireMDs MASTER Trial to be Published on November 6 in Journal of American College of Cardiology
9. InspireMD Reports Results For Period Ending Sept. 30, 2012
10. InspireMD Announces Positive Results From MGuard(TM) Stent MASTER Trial for Emergency Treatment of Heart Attack Patients
11. InspireMD to Present at Harvard Investors Group on June 27 in New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 4, 2015   Mallinckrodt plc (NYSE: ... present at the Barclays Global Healthcare Conference at the ... , on Wednesday, March 11, 2015. Mark Trudeau, President and ... in a session scheduled to begin at 10:45 a.m. ... in person can find webcast information on Mallinckrodt,s ...
(Date:3/4/2015)...  ANI Pharmaceuticals, Inc. (NASDAQ: ANIP ) announced ... Conference at the Ritz-Carlton at Laguna Niguel, California ... Arthur S. Przybyl , President and CEO, will give ... of ANI,s website at www.anipharmaceuticals.com . Mr. Przybyl,s presentation ... and available through the link through June 7, 2015. ...
(Date:3/3/2015)... JACKSONVILLE, Fla. , March 3, 2015 /PRNewswire/ ... is pleased to announce the hiring of ... Sales to lead business development efforts and build ... years of experience in software development, sales, and ... of enterprise software applications. iTraycer is a comprehensive ...
Breaking Medicine Technology:Mallinckrodt to Present at Barclays Conference March 11 2ANI Pharmaceuticals To Present At 27th Annual ROTH Conference 2Medical Tracking Solutions, Inc. Hires New SVP, Sales 2
... 27, 2011 A milestone in lupus research was met this ... Research (ALR) held its 8th annual New York City Walk ... Park was matched by the enthusiasm of the nearly 3000 walkers ... by NYC master of ceremonies, My9 news anchor Brenda Blackmon, ALR ...
... 27, 2011   FHSSA counts its partnership initiative ... known as the Foundation for Hospices in Sub-Saharan ... between US hospice programs and organizations providing care ... assistance, support and friendship.  They are working collaboratively ...
Cached Medicine Technology:Alliance for Lupus NYC Walk With Us to Cure Lupus First Lupus Walk In History To Raise $1-Million 2FHSSA Launches New Campaign to Partner US Hospices with Programs in Sub-Saharan Africa 2
(Date:3/4/2015)... 2015 The New Mel Brooks Musical ... will be performed by the award-winning Drama Department of ... March 6-22, 2015, on Fridays, Saturdays and Sundays. Performances ... School (27118 Silver Spur Road, Rolling Hills Estates, ... program or may be purchased on-line at https://sites.google.com/site/penhidrama ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Columbus is no ... steady prevalence of cocaine addiction, and suffers from the ... on Feb. 27th, the DEA revealed that Kratom is ... a herbal tea; the newly introduced herb from Southeast Asia ... in heightened doses. WKYC notes kratom foments symptoms similar to ...
(Date:3/4/2015)... 2015 The Alliance for Regenerative ... its upcoming fifth annual Advanced Therapies Summit next ... event this year will feature five expert-led interactive ... the field’s leading companies and organizations. , ... and clinical researchers from the advanced therapies community ...
(Date:3/4/2015)... Today Visiopharm announces that Patrik Dahlén, previously ... Visiopharm Board of Directors as Chairman. ... are positioned to become the fastest growing software company, ... research. , "Over the last several years, ... of ONCOtopix™ Dx, a complete quantitative digital pathology solution ...
(Date:3/4/2015)... Follow us on LinkedIn – ... increasing incidence of CNS disorders, aging population, rising healthcare ... The unmet medical needs for diagnosing and treating CNS ... market. Presently, there exists an urgent need for developing ... current generation drugs. Companies are therefore investing to develop ...
Breaking Medicine News(10 mins):Health News:The New Mel Brooks Musical Young Frankenstein Performance March 6-March 22, 2015, by the Award Winning Drama Department at Peninsula High School, Rolling Hills 2Health News:Columbus, OH Combats the Sale of Kratom as a Drug, Harbor Village Detox Stresses Caution 2Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 2Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 3Health News:Visiopharm Appoints Patrik Dahlen as Chairman of the Board 2Health News:Visiopharm Appoints Patrik Dahlen as Chairman of the Board 3Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 4
... Patients with a specific kind of lung cancer may benefit ... UCSD Cancer Center. The new drug, crizotinib, under development by ... some patients during Phase I and II clinical trials. ... encouraging," said Lyudmila Bazhenova, MD, assistant clinical professor at UC ...
... ... RE/MAX agent who participates in the “Home for the Cure™” program, through ... for the Cure when a home sale is complete. The newly rebranded ... signs, is meant to raise money for breast cancer research, education and ...
... St. Gregory Retreat ... Health Program. , ... 22, 2010 -- St Gregory Centers, Inc. announced today that they have signed agreements with ... employees. The Mayo Clinic program will be an integral part of St Gregory’s Life ...
... to be published on 21 June 2010 in the ... (Inserm unit 625 Research Group on Human and ... Hospital Centre) in Pointe Pitre (urology department, University ... the Center for Analytical Research and Technology (University of ...
... Researchers at the Oregon Health & Science University ... bioluminescence a way of measuring visible light generated from ... rapidly assessing in children at the chair-side the number of ... to tooth decay. The study is published ...
... ... to young women. They promote thinness at all costs and often disregard ... Journal of Public Health published a recent study of Pro Ana websites. This ... Stanford University School of Medicine, has raised questions about how we can meet ...
Cached Medicine News:Health News:Susan G. Komen for the Cure and RE/MAX Launch Home for the Cure™ 2Health News:Susan G. Komen for the Cure and RE/MAX Launch Home for the Cure™ 3Health News:Susan G. Komen for the Cure and RE/MAX Launch Home for the Cure™ 4Health News:St. Gregory Centers, Inc. Announces Integrating Mayo Clinic Health Wellness Program 2Health News:Chlordecone exposure and risk of prostate cancer 2Health News:OHSU School of Dentistry team examines how to rapily assess children's tooth decay risk 2Health News:Pro Ana Versus Pro Recovery Sites: New Study by Johns Hopkins and Stanford University raises concerns. 2Health News:Pro Ana Versus Pro Recovery Sites: New Study by Johns Hopkins and Stanford University raises concerns. 3
Microsurgical straight forceps made of titanium has straight shafts with smooth working surface. TCI working parts 6 mm from tips with round handle, diam. 6 mm, overall length 116 mm....
Curved tying forceps made of titanium has curved shafts with 6 mm V-grove tying platforms, width of shafts 0,5 mm, TCI platforms, flat handle, width 10 mm, overall length 103 mm....
Curved tying spring forceps made of titanium, delicate smooth jaws, length 10 mm, TCI jaws with round handle, diam. 8 mm and overall length 115 mm....
Thornton titanium curved suture tying forceps, 4"....
Medicine Products: